Supernus Pharmaceuticals
SUPN
SUPN
261 hedge funds and large institutions have $1.91B invested in Supernus Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 91 increasing their positions, 90 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
3% more capital invested
Capital invested by funds: $1.86B → $1.91B (+$48.7M)
1% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 90
0.82% less ownership
Funds ownership: 104.03% → 103.21% (-0.82%)
Holders
261
Holding in Top 10
4
Calls
$2.66M
Puts
$7K
Top Buyers
| 1 | +$16.2M | |
| 2 | +$13.9M | |
| 3 | +$9.89M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$8.03M |
| 5 |
Morgan Stanley
New York
|
+$7.66M |
Top Sellers
| 1 | -$24.5M | |
| 2 | -$12.9M | |
| 3 | -$10.6M | |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$9.26M |
| 5 |
AC
Armistice Capital
New York
|
-$8.45M |